Skip to main content
Erschienen in: BMC Pediatrics 1/2023

Open Access 01.12.2023 | Research

Treatment strategy for acute myocarditis in pediatric patients requiring emergency intervention

verfasst von: Yuka Murakoshi, Kenji Hoshino

Erschienen in: BMC Pediatrics | Ausgabe 1/2023

Abstract

Background

Patients with acute myocarditis present with a wide range of symptoms. Treatment strategies for pediatric patients with circulatory failure comprise extracorporeal membrane oxygenation (ECMO), emergency temporary pacing, and pharmacotherapy. However, they remain controversial. ECMO is an effective treatment but gives rise to several complications; the goal is therefore to avoid excessive treatment as much as possible. We aimed to evaluate the importance of electrocardiogram findings in differentiating severity and establish an appropriate treatment strategy in pediatric patients with acute myocarditis who required emergency interventions.

Methods

This retrospective study enrolled pediatric patients admitted to and treated in our hospital for acute myocarditis between April 1983 and December 2021. Patients were retrospectively divided into whether circulatory failure occurred (ECMO or temporary pacing was needed; emergency intervention group) or not (pharmacotherapy alone).

Results

Of the 26 pediatric patients, 11 experienced circulatory failure while 15 did not. In the circulatory failure group, six patients were treated with ECMO (ECMO group) and five patients with temporary pacing (pacing group). In the pacing group, all patients were diagnosed with complete and/or advanced atrioventricular block (CAVB and/or advanced AVB) and narrow QRS. Furthermore, these patients improved only with temporary pacing and pharmacotherapy, without requiring ECMO. Wide QRS complexes (QRS ≥ 0.12 ms) with ST-segment changes were detected on admission in five of six patients in the ECMO group and none in the pacing group (P = 0.015). Although all patients in the ECMO group experienced complications, none did in the pacing group (P < 0.008).

Conclusions

Regarding emergency intervention for acute myocarditis, ECMO or temporary pacing could be determined based on electrocardiogram findings, particularly wide QRS complexes with ST-segment changes on admission. It is important to promptly introduce ECMO in patients with wide QRS complexes with ST-segment changes, however, patients with CAVB and/or advanced AVB and narrow QRS could improve without undergoing ECMO. Therefore, excessive treatment should be avoided by separating ECMO from temporary pacing based on electrocardiogram findings on admission.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AV
Atrioventricular
AVB
Atrioventricular block
CAVB
Complete atrioventricular block
ECG
Electrocardiogram
ECMO
Extracorporeal membrane oxygenation
LVEF
Left ventricular ejection fraction

Introduction

Acute myocarditis refers to inflammation of the myocardium, which is characterized by leukocyte infiltration, followed by fibrosis and necrosis. It is rare, accounting for 0.05% of hospitalized pediatric patients [1]. It also has a broad range of clinical manifestations ranging from mild symptoms, such as gastroenteritis or upper respiratory tract infection and chest pain, to life-threatening arrhythmias or severe cardiogenic shock [2]. Acute myocarditis can generally be divided into fulminant and non-fulminant forms based on the severity of clinical presentation. Patients with circulatory failure may require mechanical circulatory support such as extracorporeal membrane oxygenation (ECMO) and temporary pacing. However, some cases could improve with pharmacotherapy only, including intravenous immunoglobulin, inotropes, and antiarrhythmic medication for vasoactive support, without clinically relevant residual damage [35]. Although ECMO is an effective treatment, it is associated with several complications, such as hemorrhage, neurological sequelae, and intracardiac thrombosis, especially in pediatric patients. Therefore, it is crucial to determine an accurate indication for ECMO in cases where the benefits outweigh the potential harm. However, owing to the wide variety of clinical presentations of acute myocarditis, clinical practice guidelines regarding its evaluation and treatment are still lacking [6]. Wide QRS complexes (QRS ≥ 0.12 ms) with ST-segment changes on electrocardiogram (ECG) indicate severe damage to the cardiomyocytes, secondary to intraventricular conduction delay and the cardiac conduction system block. Some studies have been conducted to assess the severity of acute myocarditis based on wide QRS complexes, which is controversial. Details of the clinical usefulness of ECG data to determine the severity of the disease are limited [79]. Although making accurate diagnoses and treatment decisions based on assessing the severity of acute myocarditis is essential, there is a dearth of clear guidelines [10].
This study aimed to evaluate the importance of ECG data on admission in differentiating the severity of acute myocarditis and establish an appropriate treatment strategy in pediatric patients with acute myocarditis requiring emergency intervention.

Methods

Patients and methods

We retrospectively reviewed the medical records of pediatric patients with acute myocarditis treated at Saitama Children’s Medical Center between April 1983 and December 2021. Acute myocarditis was diagnosed based on clinical symptoms and laboratory findings, including blood tests, chest radiography, and echocardiography, per the guidelines for diagnosing and treating acute myocarditis in Japan [6].
In general, fulminant myocarditis is defined as cases treated with ECMO or that cannot improve without ECMO treatment [11, 12], but some cases in fulminant myocarditis group do not necessarily require ECMO. Therefore, in this study, we did not use the fulminant/non-fulminant classification but the classification described below.
First, the patients were divided based on whether circulatory failure occurred (ECMO or temporary pacing was needed for recovery from circulatory failure; emergency intervention group) or not (pharmacotherapy alone). Circulatory failure in our study was defined as an inability to maintain circulation due to circulatory collapse and Stokes–Adamas seizures by atrioventricular block (AV block) according to the diagnostic criteria of the Myocardial Infarction Research Units of the National Heart and Lung Institute [13].
Second, in the emergency intervention group, patients were divided into the ECMO and temporary pacing groups. The two groups were compared by reviewing the medical records of patients. These data included clinical and anthropometric parameters such as age, sex, time from the first symptom to visiting a referring physician or our center, vital signs, ECG on admission, treatment, outcome, complications, and number of days in the hospital. The ECG on admission focused on wide QRS, defined as QRS ≧0.11 ms for up to elementary school students and QRS ≧ 0.12 ms for junior high school students, based on the Guideline for Selecting Candidates for Secondary Screening of Heart Disease in Schools (JSPCCS2019) [14]. Hypotension on admission was defined according to the 2020 Japanese Guidelines for Management of Sepsis and Septic Shock practice 2020 [15].
We obtained informed consent, and this study was approved by the Ethics Committee of Saitama Children’s Medical Center (approval number: 2021–06-019).

Statistical analysis

All statistical analyses were performed using EZR [16]. Fisher’s exact test or the Mann–Whitney U test was used for intergroup comparisons. Statistical significance was set at P < 0.050.

Results

Figure 1 describes the workflow of this study and treatment outcomes of pediatric patients with acute myocarditis. A total of 26 pediatric patients (mean age: 5.5 years, range: 0–15 years, 10 boys) with acute myocarditis were included in this study. The demographic data of all 26 pediatric patients is as follows; LV EF; median 58% (range 10–75%), duration of hospitalization; median 20 days (ranges 2–102 days), and laboratory findings such as lactic acid 1.9–12.5 mmol/L, OT/PT 24–41/13–27 s, BUN/Cr 41–70, cardiac enzyme (CK 33–17,378 U/L,CKMB 2–9%, TroI 599–6460 pg/mL), and BNP 80–3141 pg/mL. An etiology of myocarditis was determined in only one 1 of 26 cases, with parvovirus B19.
First, the patients were divided based on whether circulatory failure occurred—11 patients needed emergency intervention due to circulatory failure. However, 15 patients were treated with only pharmacotherapy. Second, the patients in the emergency intervention group were divided into two groups according to the ECG findings on admission, wide QRS complexes with ST-segment changes (rise or fall of 0.1 mV or more from J point, at least one location)—five patients had wide QRS complexes with ST-segment changes on admission. Of 11 patients required emergency intervention, six patients were treated with ECMO (the ECMO group), and five were treated with temporary pacing (the temporary pacing group). Table 1 compares the clinical characteristics and treatment outcomes between the ECMO and temporary pacing groups. There were no significant differences between the patients in the ECMO and temporary pacing group in age, sex, time from the first symptom to visiting the referring physician or our center, vital signs on admission, outcome, or duration of hospitalization. Wide QRS complexes with ST-segment changes on ECG were significantly more prominent in the ECMO group than in the temporary pacing group (P = 0.015). Concomitant medications were as follows in the ECMO group: one case under Ancalon continuous infusion; in the temporary pacing group: one case under disopyramide bolus infusion and one case during continued adrenaline support. All patients treated with ECMO had complications such as peroneal nerve palsy and intracranial disease (P = 0.008).
Table 1
A comparison of the clinical characteristics and treatment outcomes between ECMO and temporary pacing groups
 
ECMO group (n = 6)
Temporary pacing group (n = 5)
P value
Age in years (median, ranges)
6.7 ± 5.0 (5, 2–15)
9.2 ± 2.3 (10, 6–12)
0.268
Sex (male/female)
2 / 4
0 / 5
0.456
Time from the first symptom to the referring doctor's visit (days): median (ranges)
2.5 (2–6)
3.0 (2–4)
0.922
Time from first symptoms to our hospital visit (days): median (ranges)
3.0 (2–7)
4.0 (3–5)
0.508
Decreased blood pressure on admission (case)
3 (50%)
3 (60%)
1.000
Wide QRS complexes and ST-segment changes on admission (case)
5 (83%)
0 (0%)
0.015
Outcome Survived / Died (case)
4 / 2
5 / 0
0.455
Complication caused by treatment (case)
4 (100%)
0 (0%)
0.008
Hospitalization duration (days) [mean]
29.5
20
1.000
Abbreviation: ECMO Extracorporeal membrane oxygenation
Myocardial biopsies and other imaging studies, such as cardiac magnetic resonance imaging, were not performed to make a definitive diagnosis.

Treatment outcomes after emergency intervention

Patients treated with ECMO

Five patients already had circulatory collapse at arrival in the ECMO group and underwent immediate ECMO. Two patients presented with sustained ventricular tachycardia and died of cardiogenic shock while preparing for ECMO.
Wide QRS complexes with ST-segment changes on ECG were observed in five of six patients in the ECMO group. The ECG on admission in the ECMO group is shown in Figs. 2 and 3. A 6-year-old boy presented with a complete atrioventricular block (CAVB) and wide QRS complexes with ST-segment changes (Fig. 2). The patient’s condition improved with ECMO support for 4 days. A 2-year-old girl presented with CAVB and wide QRS complexes with ST-segment changes and received ECMO support for 9 days (Fig. 3). Only one patient in the ECMO group had a narrow QRS score. The patient had CAVB and mildly decreased left ventricular ejection fraction (LVEF) and was transferred to our hospital for ECMO treatment. The patient’s condition improved with ECMO support for 1 day. However, ECMO may have been unnecessary, and the patient’s condition may have improved with only pacing and pharmacotherapy.
Among the four patients treated with ECMO for 1 to 9 days, all experienced ECMO-induced complications (P < 0.05), such as peroneal nerve palsy (three cases) and intracranial disease (one case). However, all patients improved with rehabilitation.

Patients treated with temporary pacing

Table 2 shows the clinical characteristics of the pediatric patients in the temporary pacing group. All five patients experienced convulsions and syncope (Stokes–Adams seizures) within a few days after presenting with initial symptoms. On admission, none of the five patients had circulatory collapse, and all had CAVB and/or advanced AVB and narrow QRS (Fig. 4). They were treated with pacing support for 1 to 6 days and improved without complications. Pacing was effective in all patients; no patients needed a permanent pacemaker.
Table 2
Pediatric patients’ clinical characteristics in the temporary pacing group
Case No
Age (years)
LVEF (%)
VT
Atrial rate (bpm)
Recovery time (day)
Follow-up ECG
1a
12
10b
-
140
4
CRBBBs
2
10
61
-
130
3
NSR
3
10
36
-
120
6
NSR
4
8
64
-
140
1.5
NSR
5c
6
36
 + 
100
1
NSR
Abbreviations: CRBBBs complete right bundle branch block, ECG electrocardiogram, LVEF left ventricular ejection fraction (measured by M-mode echocardiography), NSR normal sinus rhythm, VT ventricular tachycardia
aUnder Disopyramide bolus infusion
bLVEF improved after pacing
cDuring continuous Adrenaline support

Patients treated with pharmacotherapy

In the non-emergency intervention group, 14 of 15 patients improved, and one patient died due to unexplained tamponade 2 months after disease onset.

Discussion

The optimal treatment strategy for acute myocarditis in pediatric patients who require emergency intervention, such as ECMO or temporary pacing, remains controversial. Based on this study of pediatric patients with acute myocarditis who underwent emergency intervention, ECMO or temporary pacing could be classified according to ECG findings on admission, particularly wide QRS complexes with ST-segment changes.
The relationship between wide QRS complexes and the severity of acute myocarditis has been reported [17, 18]. Acute myocarditis causes inflammation that affects the ventricular myocardium and cardiac conduction system, inducing systolic cardiac dysfunction and various arrhythmias. Wide QRS complexes are caused by intraventricular conduction delay or bundle branch block. Morgera et al. reported that abnormal QRS complexes were associated with more severe decreases in LVEF and a higher frequency of hypertrophy and fibrosis based on histological examination [17]. We consider that wide QRS complexes are not sinus rhythm but accelerated ventricular rhythm. The myocardial damage is wide and severe, resulting in wider QRS complexes with ST-segment changes, and the narrow QRS complexes are junctional escaped rhythms. The myocardial damage is not severe, resulting in no wide QRS. Although its molecular mechanism is unknown, a recent study showed Cx43, a principal conductor of intercellular current in the ventricle, is one of the molecular determinants for the prolongation of QRS duration [19].
In our study, all five patients treated with ECMO (except one who did not need ECMO) and no patients in the pacing group showed wide QRS complexes with ST-segment changes on admission. Therefore, ECMO or temporary pacing, as emergency interventions in pediatric patients with acute myocarditis, could be classified based on wide QRS complexes with ST-segment changes on admission. Therefore, this strategy is superior to introduce actively ECMO therapy, based on previous case reports in which patients were saved only by temporary pacing and this study. In addition, I consider this strategy more appropriate than introducing more active ECMO, because narrow QRS complexes suggest no extensive and intense myocardial damage.
In our study, we did not perform myocardial biopsy because of an environment in which it can not be performed at our facility. Therefore, we made a comprehensive diagnosis based on symptoms and various laboratory findings.

Indication for ECMO

ECMO is generally effective in patients with acute myocarditis with circulatory failure. However, to date, no criteria for ECMO intervention are available. The relationship between the severity of acute myocarditis and ECG findings, including adult cases, has been reported [10, 2022].
Wide QRS complexes in patients with acute myocarditis were among the earliest identifiable clinical signs and indicators of poor prognosis. Additionally, they represented the only independent factor significantly associated with a fulminant course of acute myocarditis [2022]. Zhang et al. reported that in adult patients (39 ± 14 years) with acute myocarditis, wide QRS complexes on admission in the severe group were predominantly higher than those in the non-severe group. In addition, in the severe group, the non-surviving group had wide QRS complexes significantly more predominant than those in the surviving group [23].
In our study, circulatory failure and wide QRS complexes with ST-segment changes on admission were predominantly observed in the ECMO group. However, the patients in this group improved rapidly with ECMO. We suggest that wide QRS complexes with ST-segment changes in patients with acute myocarditis might be associated with a high risk of circulatory failure and require ECMO support. Therefore, we recommend the prompt use of ECMO in pediatric patients with wide QRS complexes and ST-segment changes on admission.

Indication for temporary pacing

Acute myocarditis complicated by CAVB and/or advanced AVB is rare in children. Although there are several pediatric studies on acute myocarditis, patients with CAVB were mainly described in case reports. Moreover, the outcomes of CAVB complicated by myocarditis are variable.
Some studies reported that temporary pacing for 1 to 10 days was effective, although permanent pacemakers were sometimes needed [2430]. Wang et al. reported that temporary pacing and pharmacotherapy were effective in nine pediatric patients (age range: 10 months to 13 years) with acute myocarditis accompanied with CAVB [24], three of whom had ventricular tachycardia in addition to CAVB, and five had Stokes–Adams seizures. In eight patients, cardiac rhythm returned to a normal sinus rhythm within 3.5 ± 3.3 days (range: 0.5–10 days) with temporary pacing, except for one case with an implanted permanent pacemaker. Batra et al. reviewed 40 pediatric patients (mean age: 10.1 ± 6.1 years) with acute myocarditis complicated by advanced AVB [25]. Of the 38 patients treated with temporary pacing in this study, 27 recovered from AV conduction delay. The average time for recovery from AV conduction delay was 3.3 ± 2.8 days. One study reported that persistent CAVB was 22% in children (mean age: 9.5 ± 4.2 years), in which permanent pacemaker implantation could be considered [31].
In our study, patients with CAVB and/or advanced AVB showed narrow QRS. Therefore, we considered the myocardial inflammation not severe and decided on temporary pacing without ECMO. All patients with CAVB and/or advanced AVB and narrow QRS improved with temporary pacing and pharmacotherapy. In addition, there were no cases in which the QRS width increased over time in patients with narrow QRS complexes on admission. None of the patients required ECMO later owing to ineffective temporary pacing.
We suggest that temporary pacing could be effective, and ECMO might not be required in pediatric patients with CAVB and/or advanced AVB and narrow QRS. Regarding emergency interventions for acute myocarditis, conduction system failure improves during temporary pacing, and hence, ECMO can be avoided in these cases. Therefore, excessive treatment should be avoided by separating ECMO from temporary pacing based on ECG findings on admission.
However, there are cases in which the general condition and laboratory findings change rapidly. In our study, there were not any cases where the electrocardiogram or circulatory status changes after hospitalizationafter, but it is quite possible and we need to consider how to respond to such cases. If such status changes after admission, we follow the same approach, stratify the patient again by ECG findings, and consider therapeutic intervention based on these findings.

Clinical complications of ECMO

Although ECMO is effective, complications suffer from ECMO such as hemorrhage, thrombus formation, internal cranial hemorrhage, cerebral infarction, and neurological sequelae are common [32]. Neurological sequelae includes subarachnoid hemorrhage, ischemic watershed infarctions, hypoxic-ischemic encephalopathy, unexplained coma, and brain death, which has potentially fatal neurological diagnoses and it is associated with significant increase in mortality [33, 34]. The children have more neurologic complications than adults [35]. Neurological complications are highly variable ranging between 4–37%, and the incidence of major neurologic morbidity in cardiac patients is highest in neonates, specifically, with 7% suffering seizures, 3.5% infarction, and 11% intracranial hemorrhage. Children have slightly lower incidence of seizures and hemorrhage and a slightly higher incidence of infarction. On the other hand, serious complications of temporary pacing include infection, pneumothorax, air emboli, and cardiac tamponade. However, there have been few reports of such complications leading to interrupted pacing or death in children [31]. In this study, pediatric patients treated with ECMO had more side effects than those treated with temporary pacing (P < 0.05). Therefore, in pediatric patients with acute myocarditis undergoing emergency intervention, we propose avoiding unnecessary ECMO treatment due to its possible side effects. 

Strengths and limitations

Our study has several limitations. It was a single-center retrospective study with a relatively small number of patients. In addition, a myocardial biopsy was not performed. However, our study might be valuable because there are very few studies focusing on the relationship between disease severity, and wide QRS complexes with ST-segment changes on admission. Large-scale prospective studies are required to validate these findings.

Conclusion

In pediatric patients with acute myocarditis undergoing emergency interventions, it is essential to classify ECMO or temporary pacing in terms of therapeutic efficacy and complications based on ECG findings on admission. In patients with wide QRS complexes with ST-segment changes on admission, ECMO is required immediately. However, temporary pacing could be effective in patients with CAVB and/or advanced AVB and narrow QRS, and ECMO might not be necessary.
It is essential to promptly administer ECMO in patients with wide QRS complexes with ST-segment changes on admission. Conversely, patients with narrow QRS without circulatory collapse could improve without ECMO administration. In pediatric patients with acute myocarditis undergoing emergency intervention, ECMO or temporary pacing could be classified based on wide QRS complexes with ST segment changes on admission. Therefore, excessive treatment should be avoided by separating ECMO from temporary pacing.

Acknowledgements

We would like to thank S. Kawachi, K. Momoki, M. Nishioka, K. Yoshida, K. Kogawa, and E. Kittaka for useful discussions. We also thank the members of PICU (Pediatric Intensive Care Unit)/HCU (High Care Unit) and the infection control team for attentive medical care.

Declarations

This study was performed in accordance with the Declaration of Helsinki and all relevant guidelines and regulations.
We obtained informed consent from the parents and this study was approved by the Ethics Committee of Saitama Children’s Medical Center (approval number: 2021–06-019). The data used in this study was anonymised before its use.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Klugman D, Berger JT, Sable CA, et al. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol. 2010;31:222–8.CrossRefPubMed Klugman D, Berger JT, Sable CA, et al. Pediatric patients hospitalized with myocarditis: a multi-institutional analysis. Pediatr Cardiol. 2010;31:222–8.CrossRefPubMed
3.
Zurück zum Zitat Ammirati E, Cipriani M, Moro C, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: the multicenter Lombardy registry. Circulation. 2018;138:1088–99.CrossRefPubMed Ammirati E, Cipriani M, Moro C, et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: the multicenter Lombardy registry. Circulation. 2018;138:1088–99.CrossRefPubMed
4.
Zurück zum Zitat Ammirati E, Cipriani M, Lilliu M, et al. Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis. Circulation. 2017;136:529–45.CrossRefPubMed Ammirati E, Cipriani M, Lilliu M, et al. Survival and left ventricular function changes in fulminant versus nonfulminant acute myocarditis. Circulation. 2017;136:529–45.CrossRefPubMed
5.
Zurück zum Zitat Veronese G, Cipriani M, Petrella D, et al. Not every fulminant lymphocytic myocarditis fully recovers. J Cardiovasc Med. 2018;19:453–4.CrossRef Veronese G, Cipriani M, Petrella D, et al. Not every fulminant lymphocytic myocarditis fully recovers. J Cardiovasc Med. 2018;19:453–4.CrossRef
6.
Zurück zum Zitat JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ J. 2011;75:734–43.CrossRef JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ J. 2011;75:734–43.CrossRef
7.
Zurück zum Zitat Caforio ALP, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636–248.CrossRefPubMed Caforio ALP, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636–248.CrossRefPubMed
8.
Zurück zum Zitat Aoyama N, Izumi T, Hiramori K, et al. National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis. Circ J. 2002;66:133–44.CrossRefPubMed Aoyama N, Izumi T, Hiramori K, et al. National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis. Circ J. 2002;66:133–44.CrossRefPubMed
9.
Zurück zum Zitat Lin KM, Li MH, Hsieh KS, et al. Impact of extracorporeal membrane oxygenation on acute fulminant myocarditis-related hemodynamic compromise arrhythmia in children. Pediatr Neonatol. 2016;57:480–7.CrossRefPubMed Lin KM, Li MH, Hsieh KS, et al. Impact of extracorporeal membrane oxygenation on acute fulminant myocarditis-related hemodynamic compromise arrhythmia in children. Pediatr Neonatol. 2016;57:480–7.CrossRefPubMed
10.
Zurück zum Zitat Ukena C, Mahfoud F, Kindermann I, et al. Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur J Heart Fail. 2011;13:e398–405.CrossRef Ukena C, Mahfoud F, Kindermann I, et al. Prognostic electrocardiographic parameters in patients with suspected myocarditis. Eur J Heart Fail. 2011;13:e398–405.CrossRef
11.
12.
Zurück zum Zitat McCarthy RE, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000;342:690–5.CrossRefPubMed McCarthy RE, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000;342:690–5.CrossRefPubMed
13.
Zurück zum Zitat Swan HJ, Forrester JS, Diamond G, et al. Hemodynamic spectrum of myocardial infarction and cardiogenic shock. A conceptual model. Circulation. 1972;45:1097–110.CrossRefPubMed Swan HJ, Forrester JS, Diamond G, et al. Hemodynamic spectrum of myocardial infarction and cardiogenic shock. A conceptual model. Circulation. 1972;45:1097–110.CrossRefPubMed
14.
Zurück zum Zitat Mamoru A, Mari I, Yoshiaki K, et al. Guideline for Selecting Candidates for Secondary Screening of Heart Disease in Schools: Electocardiographic Findings of the Initial Screening (JSPCCS2019). Pediatric Cardiology and Cardiac Surgery. 2019;35:S3.1-S3.12. Mamoru A, Mari I, Yoshiaki K, et al. Guideline for Selecting Candidates for Secondary Screening of Heart Disease in Schools: Electocardiographic Findings of the Initial Screening (JSPCCS2019). Pediatric Cardiology and Cardiac Surgery. 2019;35:S3.1-S3.12.
15.
Zurück zum Zitat Egi M, Ogura H, Yatabe T, et al. The japanese clinical practice guidelines for management of Sepsis and Septic Shock 2020 (J-SSCG 2020). Acute Med Surg. 2021;8:e659.CrossRefPubMedPubMedCentral Egi M, Ogura H, Yatabe T, et al. The japanese clinical practice guidelines for management of Sepsis and Septic Shock 2020 (J-SSCG 2020). Acute Med Surg. 2021;8:e659.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRefPubMed
17.
Zurück zum Zitat Morgera T, Lenarda AD, Dreas L, et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. Am Heart J. 1992;124:455–67.CrossRefPubMed Morgera T, Lenarda AD, Dreas L, et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. Am Heart J. 1992;124:455–67.CrossRefPubMed
18.
Zurück zum Zitat Jhamnani S, Fuisz A, Lindsay J. The spectrum of electrocardiographic manifestations of acute myocarditis: an expanded understanding. J Electrocardiol. 2014;47:941–7.CrossRefPubMed Jhamnani S, Fuisz A, Lindsay J. The spectrum of electrocardiographic manifestations of acute myocarditis: an expanded understanding. J Electrocardiol. 2014;47:941–7.CrossRefPubMed
19.
Zurück zum Zitat Zhong C, Chang H, Wu Y, et al. Up-regulated Cx43 phosphorylation at Ser368 prolongs QRS duration in myocarditis. J Cell Mol Med. 2018;22:3537–47.CrossRefPubMedPubMedCentral Zhong C, Chang H, Wu Y, et al. Up-regulated Cx43 phosphorylation at Ser368 prolongs QRS duration in myocarditis. J Cell Mol Med. 2018;22:3537–47.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Elamm C, Fairweather D, Cooper LT. Republished: pathogenesis and diagnosis of myocarditis. Postgrad Med J. 2012;88:539–44.CrossRefPubMed Elamm C, Fairweather D, Cooper LT. Republished: pathogenesis and diagnosis of myocarditis. Postgrad Med J. 2012;88:539–44.CrossRefPubMed
21.
Zurück zum Zitat Buttà D, Zappia L, Laterra G, et al. Diagnostic and prognostic role of electrocardiogram in acute myocarditis: a comprehensive review. Ann Noninvasive Electrocardiol. 2020;25:e12726.CrossRefPubMed Buttà D, Zappia L, Laterra G, et al. Diagnostic and prognostic role of electrocardiogram in acute myocarditis: a comprehensive review. Ann Noninvasive Electrocardiol. 2020;25:e12726.CrossRefPubMed
22.
Zurück zum Zitat Lee CH, Tsai WC, Hsu CH, et al. Predictive factors of a fulminant course in acute myocarditis. Int J Cardiol. 2006;109:142–5.CrossRefPubMed Lee CH, Tsai WC, Hsu CH, et al. Predictive factors of a fulminant course in acute myocarditis. Int J Cardiol. 2006;109:142–5.CrossRefPubMed
24.
Zurück zum Zitat Wang JN, Tsai YC, Lee WL, et al. Complete atrioventricular block following myocarditis in children. Pediatr Cardiol. 2002;23:518–21.CrossRefPubMed Wang JN, Tsai YC, Lee WL, et al. Complete atrioventricular block following myocarditis in children. Pediatr Cardiol. 2002;23:518–21.CrossRefPubMed
25.
Zurück zum Zitat Batra AS, Epstein D, Silka MJ. The clinical course of acquired complete heart block in children with acute myocarditis. Pediatr Cardiol. 2003;24:495–7.CrossRefPubMed Batra AS, Epstein D, Silka MJ. The clinical course of acquired complete heart block in children with acute myocarditis. Pediatr Cardiol. 2003;24:495–7.CrossRefPubMed
26.
Zurück zum Zitat Heitink-Pollé KMJ, Rammeloo L, Hruda J, et al. Rapid and full recovery after life-threatening complete atrioventricular block: an isolated feature of myocarditis? Eur J Pediatr. 2004;163:410–1.CrossRefPubMed Heitink-Pollé KMJ, Rammeloo L, Hruda J, et al. Rapid and full recovery after life-threatening complete atrioventricular block: an isolated feature of myocarditis? Eur J Pediatr. 2004;163:410–1.CrossRefPubMed
27.
Zurück zum Zitat Lim CH, Toh CC, Chia BL, et al. Stokes-Adams attacks due to acute nonspecific myocarditis. Am Heart J. 1975;90:172–8.CrossRefPubMed Lim CH, Toh CC, Chia BL, et al. Stokes-Adams attacks due to acute nonspecific myocarditis. Am Heart J. 1975;90:172–8.CrossRefPubMed
28.
Zurück zum Zitat Matisonn RE, Mitha AS, Chesler E. Successful electrical pacing for complete heart block complicating diphtheritic myocarditis. Br Heart J. 1976;38:423–6.CrossRefPubMedPubMedCentral Matisonn RE, Mitha AS, Chesler E. Successful electrical pacing for complete heart block complicating diphtheritic myocarditis. Br Heart J. 1976;38:423–6.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Granath A, Kimby E, Södermark T, et al. Stokes-Adams attacks requiring pacemaker treatment in three patients with acute nonspecific myocarditis. Acta Med Scand. 1980;207:177–81.CrossRefPubMed Granath A, Kimby E, Södermark T, et al. Stokes-Adams attacks requiring pacemaker treatment in three patients with acute nonspecific myocarditis. Acta Med Scand. 1980;207:177–81.CrossRefPubMed
30.
Zurück zum Zitat Gupta RD, Das MK, Mitra S, et al. Acute nonspecific carditis in adolescents presenting with Stokes-Adams attacks. J Assoc Physicians India. 1999;47:1195–7.PubMed Gupta RD, Das MK, Mitra S, et al. Acute nonspecific carditis in adolescents presenting with Stokes-Adams attacks. J Assoc Physicians India. 1999;47:1195–7.PubMed
31.
Zurück zum Zitat Chien SJ, Liang CD, Lin IC, et al. Myocarditis complicated by complete atrioventricular block: nine years’ experience in a medical center. Pediatr Neonatol. 2008;49:218–22.CrossRefPubMed Chien SJ, Liang CD, Lin IC, et al. Myocarditis complicated by complete atrioventricular block: nine years’ experience in a medical center. Pediatr Neonatol. 2008;49:218–22.CrossRefPubMed
32.
Zurück zum Zitat Makdisi G, Wang W. Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis. 2015;7:E166–76.PubMedPubMedCentral Makdisi G, Wang W. Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis. 2015;7:E166–76.PubMedPubMedCentral
33.
Zurück zum Zitat Mateen FJ, Muralidharan R, Shinohara RT, et al. Neurological Injury in adults treated with extracorporeal membrane oxygenation. Arch Neurol. 2011;68:1543–9.CrossRefPubMedPubMedCentral Mateen FJ, Muralidharan R, Shinohara RT, et al. Neurological Injury in adults treated with extracorporeal membrane oxygenation. Arch Neurol. 2011;68:1543–9.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Tanaka D, Hirose H, Cavarocchi N, et al. The impact of vascular complications on survival of patients on venoarterial extracorporeal membrane oxygenation. Ann Thorac Surg. 2016;101:1729–34.CrossRefPubMed Tanaka D, Hirose H, Cavarocchi N, et al. The impact of vascular complications on survival of patients on venoarterial extracorporeal membrane oxygenation. Ann Thorac Surg. 2016;101:1729–34.CrossRefPubMed
35.
Zurück zum Zitat Mehta A, Ibsen LM. Neurologic complications and neurodevelopmental outcome with extracorporeal life support. World J Crit Care Med. 2013;2:40–7.CrossRefPubMedPubMedCentral Mehta A, Ibsen LM. Neurologic complications and neurodevelopmental outcome with extracorporeal life support. World J Crit Care Med. 2013;2:40–7.CrossRefPubMedPubMedCentral
Metadaten
Titel
Treatment strategy for acute myocarditis in pediatric patients requiring emergency intervention
verfasst von
Yuka Murakoshi
Kenji Hoshino
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Pediatrics / Ausgabe 1/2023
Elektronische ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-023-04200-0

Weitere Artikel der Ausgabe 1/2023

BMC Pediatrics 1/2023 Zur Ausgabe

Mit dem Seitenschneider gegen das Reißverschluss-Malheur

03.06.2024 Urologische Notfallmedizin Nachrichten

Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.